0 NASDAQ Companies - October 9, 2024Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer DeviceFREEHOLD, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of […]Read More
0 NASDAQ Companies - October 9, 2024Mather Al-Ali Joins Vislink as Vice President of Sales for Middle East and Africa RegionMt. Olive, New Jersey, Oct. 09, 2024 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (NASDAQ: VISL), a global leader in live […]Read More
0 TSX Venture News - October 9, 2024SAGA Metals Completes Field Program at Double Mer Uranium Project, Identifying High-Priority Zones for ExpansionVANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“TSXV: SAGA”) (“FSE: 20H”) (“SAGA” or the “Company”), […]Read More
0 TSX Venture News - October 9, 2024EnWave Announces Issuance of Company-Wide Stock Options and RSRsVANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today […]Read More
0 NYSE Companies - October 9, 2024AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLCOCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that […]Read More
0 NASDAQ Companies - October 9, 2024Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16thSOLANA BEACH, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on […]Read More
0 NASDAQ Companies - October 9, 2024Air Capital Wealth Management Launches with LPL FinancialSAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) announced today that financial advisors Michael Caffrey, CRPC®, Derek […]Read More
0 NASDAQ Companies - October 9, 2024Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and […]Read More
0 NASDAQ Companies - October 9, 2024ECD Auto Design Spotlights Premium Accessories for One-Of-One Vehicle TransformationsKISSIMMEE, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) — ECD Auto Design, a leader in custom, one-of-one luxury vehicle restorations, specializing […]Read More
0 NASDAQ Companies - October 9, 2024WTW launches partnership with the University of Colorado Boulder to harness the climate prediction revolutionLONDON, Oct. 09, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company today announced […]Read More